"Translocation, Genetic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type of chromosome aberration characterized by CHROMOSOME BREAKAGE and transfer of the broken-off portion to another location, often to a different chromosome.
Descriptor ID |
D014178
|
MeSH Number(s) |
C23.550.210.870 G05.365.590.175.870 G05.558.860
|
Concept/Terms |
Translocation, Genetic- Translocation, Genetic
- Genetic Translocation
- Genetic Translocations
- Translocations, Genetic
- Chromosomal Translocation
- Chromosomal Translocations
- Translocations, Chromosomal
- Translocation, Chromosomal
|
Below are MeSH descriptors whose meaning is more general than "Translocation, Genetic".
Below are MeSH descriptors whose meaning is more specific than "Translocation, Genetic".
This graph shows the total number of publications written about "Translocation, Genetic" by people in this website by year, and whether "Translocation, Genetic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 3 | 0 | 3 |
1996 | 2 | 1 | 3 |
1997 | 1 | 0 | 1 |
1998 | 1 | 0 | 1 |
1999 | 2 | 1 | 3 |
2000 | 1 | 1 | 2 |
2001 | 2 | 1 | 3 |
2003 | 2 | 3 | 5 |
2004 | 0 | 2 | 2 |
2005 | 1 | 1 | 2 |
2006 | 1 | 0 | 1 |
2007 | 2 | 2 | 4 |
2008 | 1 | 0 | 1 |
2009 | 1 | 2 | 3 |
2010 | 2 | 2 | 4 |
2011 | 0 | 2 | 2 |
2012 | 2 | 2 | 4 |
2013 | 0 | 1 | 1 |
2014 | 1 | 0 | 1 |
2018 | 0 | 1 | 1 |
2020 | 1 | 0 | 1 |
2021 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Translocation, Genetic" by people in Profiles.
-
PARP-1 activation leads to cytosolic accumulation of TDP-43 in neurons. Neurochem Int. 2021 Sep; 148:105077.
-
Increased Incidence of IKZF1 deletions and IGH-CRLF2 translocations in B-ALL of Hispanic/Latino children-a novel health disparity. Leukemia. 2021 08; 35(8):2399-2402.
-
Integrated genomic analysis using chromosomal microarray, fluorescence in situ hybridization and mate pair analyses: Characterization of a cryptic t(9;22)(p24.1;q11.2)/BCR-JAK2 in myeloid/lymphoid neoplasm with eosinophilia. Cancer Genet. 2020 08; 246-247:44-47.
-
Discovery platform for inhibitors of IgH gene enhancer activity. Cancer Biol Ther. 2019; 20(4):571-581.
-
Analysis of the t(3;8) of hereditary renal cell carcinoma: a palindrome-mediated translocation. Cancer Genet. 2014 Apr; 207(4):133-40.
-
6-Mercaptopurine augments glucose transport activity in skeletal muscle cells in part via a mechanism dependent upon orphan nuclear receptor NR4A3. Am J Physiol Endocrinol Metab. 2013 Nov 01; 305(9):E1081-92.
-
Sangivamycin-like molecule 6 exhibits potent anti-multiple myeloma activity through inhibition of cyclin-dependent kinase-9. Mol Cancer Ther. 2012 Nov; 11(11):2321-30.
-
Numb chin syndrome in acute myeloid leukemia. Am J Med Sci. 2012 Sep; 344(3):237-40.
-
Unbalanced translocation involving partial trisomy 9p and partial monosomy yq with neurodevelopmental delays. J Child Neurol. 2013 Apr; 28(4):524-6.
-
Association of age with fluorescence in situ hybridization abnormalities in multiple myeloma reveals higher rate of IGH translocations among older patients. Leuk Lymphoma. 2012 Dec; 53(12):2444-8.